CLINICAL_TRIALS
trial_result
· 2018-08-22
Clinical Trial Update: Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument [Phase 3]
Summary
Phase 3 trial update for macitentan in pulmonary arterial hypertension focusing on psychometric validation of the PAH-SYMPACT instrument; study terminated with …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2018-08-22